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Abstract

Introduction

Ring shaped
ocular
inserts
have been
developed
to administer
a therapeutic
level
of
tylosin
tartrate
throughout
a five day period
to treat
pinkeye
in cattle.
The inserts
are
based on polyvinyl
chloride
rings
which are dip
coated
with a copolymer
containing
the antibiotic
(tylosin
tartrate).
Scanning
electron
microscope
(SEM) characterization
of surfaces
has been of value
to evaluate
the presence
and
extent
of surface
flaws in the hydrogel
coating,
and to contribute
to improvement
in
fabrication
of the rings
to insure
the
establishment
of satisfactory
seals
at joints,
uniformity
of microporosity
and cross
sections,
and the absence
of significant
cracking
or
flaking.
In vitro
release
rates
were determined using-thin
layer
chromatography
techniques,
and rates
were seen to be above a
few micrograms
of antibiotic
p0r hour for
experiments
as long as nine days at simulated
tear
rates
as high as 2 milliliters
per hour.

The treatment
of certain
eye diseases
can
De significantly
improved
over that
of conventional
treatments,
such as eyedrops,
by using
controlled
drug release
ocular
inserts.
An
example
of a disease
of potential
interest
where
this
type of treatment
method could
be
advantageous
is pinkeye
in cattle.
To be
effective
such inserts
must release
a therapeutic
level
of drug continuously,
and must be
non-irritating
to the eye.
Other factors,
such
as cost,
are also
important.
Ideally,
a bioerodable
device
might be preferred,
but a
device
that
will
remain
in place
throughout
an
appropriate
time period,
and that
can be easily
removed,
would certainly
be satisfactory.
The characteristics
of pinkeye
in cattle
(Bovine
Infectious
Keratoconjunctivitis,
BIK,
or IBK) are lacrimation,
photophobia,
corneal
ulcers,
and corneal
opacities.
It is a
contagious
disease,
and can result
in significant economic
losses
associated
with weight
loss
and decrease
in milk production.
In the
State
of Iowa, six to ten percent
of weaned
beef calves
suffer
significant
enough damage
from pinkeye
to reduce
their
economic
value
by 1/3 to 1/2.
This represents
a loss of tens
of millions
of dollars
in Iowa alone.
A virulent
form of Moraxella
bovis,
a
common agricultural
bacterium,
is t~primary
infectious
agent
of BIK (Pugh and Hughes,
1968;
Hughes and Pugh,
1970).
Current
medication
application
techniques
exhibit
severe
drawbacks
such as rapid
removal
of ointments
or drops
by
tear
fluids.
The primary
method for ocular
delivery
of antibiotic
solutions
is the use of
eyedrops.
A considerable
fraction
of an eyedrop is lost
immediately
after
instillation
(about
80 percent
in h~mans;
Gelatt
et al.,
1979); the primary
disadvantage
of usual
aqueous
eyedrop
preparations
is the short
duration
of drug action.
For comparable
time
periods,
sprays
produce
drug action
results
similar
to those
achieved
by using
eyedrops
(Chiou and Watanabe,
1982).
For example,
a
30 mg dose of tylosin
tartrate
[c 45 H77 No 17-c 4 H6o 6 J applied
to the eyes of
cattle
twice daily
as a 50 milligrams/ml
aqueous
spray
eliminated
clinical
signs
of
BIK and Moraxella
bovis
after
five
days (Ellis
and Barnes,
1961); an in vitro
test
on a
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(1979) is followed
to make the copolymer used
for dip coating.
This is a batch process
in
which the copolymer forms throughout
a ten day
period.
The following
components are added
together
to obtain
the desired
90 mole percent
methyl methacrylate
- 10 mole percent
hydroxyethyl
methacrylate
bulk copolymer;
570 ml
ethanol,
380 ml water (type-one),
6.1 ml 2hydroxyethyl
methacrylate
(Polysciences
Inc.,
Warrington,
PA; opthalmic
grade),
46.6 ml methyl
methacrylate,
0.25 g sodium persulfate,
and
0.13 g potassium
persulfate.
Throughout a ten
day period,
the solution
is bubbled with nitrogen.
At the end of the ten day period,
the l
liter
solution
and white copolymer precipitate
is added to 3 liters
of water, and the precipitate copolymer is filtered
and dried
(50° C for
five days, 635 mm Hg vacuum).
Quantities
of the copolymer are then dissolved in a suitable
solvent
and the drug is
then mixed into the solution.
This forms the
dip coating
material.
For example, a representative
batch would consist
of lg of copolymer and 20 ml of dimethyl
formamide (stirred at 40-45° C for 6 hours).
The solution
is
then cooled to room temperature
before the
addition
of 0.5 g of tylosin
tartrate.
Vinyl tubing
(polyvinyl
chloride,
medical
grade, both regular
(i.d.
0.112cm x o.d.
0.165cm) and radiopaque
(i.d.
0.086cm x o.d.
0.117cm) varieties)
is cut into suitable
lengths
(e.g.,
126 mm long to permit making a ring
40 mm in diameter).
This tubing is threaded
onto a wire which is subsequently
bent into a
ring shape prior to dipping.
The dipping procedure is done in an inert
atmosphere
(nitrogen
in a glove bag; Drierite
desiccant)
to insure
uniformity
of microstructure.
To build up a
sufficient
amount of polymer and dissolved
drug, ten to fifteen
dips are made, and the surface is allowed to dry between subsequent
dips.
The weight is monitored
so that the amount of
drug in a ring device is approximately
50
milligrams.
(Note that this total
amount of
drug loading
per device is of the order of a
typical
single
eyedrop application
of antibiotic.)
A thinner
(i.d.
0.051cm x o.d. 0.091cm),
1cm length of radiopaque
polyvinyl
chloride
tubing is then wetted with either
a polyvinyl
chloride
- tetrahydrofuran
solution
(5 weight
percent
PVC in tetrahydrofuran)
or a solution
of the copolymer in dimethyl
formamide and
inserted
into the ends of the dipped ring
shaped tubing
(removing the wire mandrel first);
this results
in a strong joint,
and completes
the ring.
Drug Release Characterization
In vitro
drug release
experiments
were conductedusing
Ringer's
solution
as an elution
medium.
The quantitative
method for measuring
drug release
is based on thin layer chromatography (TLC) (Ryoo (1986)).
The presence
of
salt broadens
the spots used in the TLC method;
however, the amounts of the drug are determinEd
at the microgram level.
For in vitro
drug release
experiments,
a
continuousflow
apparatus
was used and the salt
solution
flowed over the ring at a rate of 2

Moraxella
bovis isolate
demonstrated
inhibition by tylosin
at a level of 0.4 micrograms
per ml.
This antibiotic
also possesses
inhibitory
action on several
members of the
genus Mycoplasma, foe example.
Recent work has
shown that Mycoplasma bovoculi
enhances
the
colonization
of cattle
eyes by Moraxella
bovis
(Rosenbusch,
1983, 1985; Rosenbusch and
Knudtson,
1980).
Improvements may be made in the administration
of therapeutic
levels
of such an
antibiotic
by use of specialized
ocular
inserts
for controlled
release.
Several
studies
have
contributed
supplemental
information
in support
of this concept.
For example, Hughes and Pugh
(1975) found that 42.9 to 44.5 millimeter
diameter
rings constructed
of polyvinyl
chloride
tubing
(outside
diameters
of 2.82,
1.65, or 0.914 millimeters)
could be retained
in the bovine eye.
0lanoff
and co-workers
(1979) demonstrated
that certain
hydrogel
copolymers
were capable of releasing
microgram/
hour quantities
of tetracycline
(using
copolymer areas and thicknesses
roughly
comparable
to those of interest
for potential
ring-shaped
ocular insert
applications
as will
be described
in the current
work), a relatively
large molecule,
from a trilaminate
delivery
disk for periods
of the order of months in in
vitro
diffusion
studies
using Ringer's
solution
[8.60 g NaCl, 0.30 g KCl, 0.33 g CaCl2 in 1.00
1 aqueous solution)
at 37° C. By varying
the
relative
percentage
of 2-hydroxyethyl
methacrylate
(hydrophilic
monomer component)
and methyl methacrylate
(hydrophobic
monomer
component) of a copolymer,
the diffusivity
of
the tetracycline
through the copolymer could
be varied over a range of values.
Thus, this
copolymer system appeared
to offer general
characteristics
of interest
for use in
developing
ring-shaped
ocular
controlled
drug
release
devices
in which an antibiotic
such as
tylosin
tartrate
could be of value.
Hoffmann and Spadbrow (1978) reported
mean lachrymal
flow rates
in cattle
of 0.181.86 ml/h;
Slatter
and Edwards (1982)
measured mean flow rates of l.96+/-1.84
ml/h
(+/-s.d.).
Disease or other conditions
will
affect
flow rates;
a relatively
high flow rate
of 2 rnl/h
was chosen as representative
of a
condition
of irritation.
The instantaneous
volume of lachrymal
fluid
in the bovine eye may
be approximated
as 0.5 ml (R. Rosenbusch,
personal
communication).
As the minimum
inhibitory
concentration
for Moraxella
bovis
isolates
is low, and of the order of 0.5
microgram/ml
(MIC; taken as the lowest concentration
of antimicrobial
agent at which the
tested
organism did not show growth),
desired
drug release
rates
from the insert
system would
be anticipated
to be at least
of the order of
a few micrograms/h.
Materials
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Materials
Fabrication
Room temperature
copolymerization
according to the method of 0lanoff
and co-workers
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presence
or absence
impurities.

ml/hr.
A 2 ml sample was collected
on an
hourly basis.
A sample was dried,
then
redissolved
in water to a suitable
concentration level for spotting
on 20 cm x 20 cm TLC
plates.
Several
tests
were done to insure
that
the concentration
level was within a range for
standards
spotted
on the same plate.
Whatman
LKC13F TLC plates
were analyzed
using a Kontes
Fiber Optics Scanner
(model 800) and a chart
recorder.
This type of TLC plate
(linear-K
plate with a preabsorbent
area) uses a silica
gel medium with hydrocarbonaceous
functional
groups covalently
bonded to surface
hydroxyls
of the silica
gel (related
to the c
part of
18
the plate designation).
Also, octadecylsilane
is bonded to the silica
gel.
The material
is
fluorescent
(absorbs
254 nanometer
light),
giving dark spots on a green background.
To
pcovide a more uniform visualization,
the silicone coating
is first
removed from a clean
plate by treating
the plate with methanol and
drying.
After this plate pretreatment,
2.5
microliter
droplets
of the samples and standards are spotted
onto the preadsorbent
area
of a plate
(10 spots/plate),
and dried at room
temperature.
The plate
is developed
in an 85%
methanol - 15% water solution
causing
a spot
migration
of the order of 10 centimeters.
The
plates
are then air dried for a 1 h period;
ultraviolet
light
is then used to check the
spots to insure
that the drug release
samples
are within
the concentration
range represented
by the standards
on the same plate.
Then the
TLC plate is sprayed with a 10% H2 so4 - 90%
methanol solution
(at a rate of 15 ml/min for
15 sec).
The plate
is then placed in a preheated oven at 100° C for 5 min.
The spots
will now be visible
without
the UV light.
The
plate is analyzed
on the Kontes system within
15 min of removal of a plate from the oven
(fading occurs within
3 h).
Each spot is
analyzed
twice;
the peaks are cut from the
chart paper,
and are weighed.
The quantity
of
drug in a release
sample is determined
by
linear
interpolation
in reference
to the peak
weights for the standards
(Touchstone
and
Dobbins (1978); Leytem (1984)).
Scanning Electron
Microscopy
Before and after
release
experiments,
representative
hydrogel
coated ring specimens
are cut into 1 cm lengths.
In vitro
release
experiment
samples are usually
air dried,
and
mounted on carbon stubs.
Some samples are
critical
point dried in a Polaron Model E3000 0
drier
using CO2. The specimens
receive
a 300 A
coating
of gold (Polaron
E5100 sputter
coater),
and then are examined using an SEM (JEOL U3
equipped with an energy dispersive
X-ray analysis system and JSM 840-A; the photos which are
shown were obtained
from the JSM 840-A).
Operating
conditions
of relatively
low probe
0
current
(~3 x 10-ll A) and relatively
low
accelerating
voltages
(5-10 kV) are generally
preferred
to avoid beam damage to sample surfaces.
An energy dispersive
X-ray analysis
(Tracor Northern
- 2000 energy dispersive
analysis
system; Kevex detector)
is also done
on the PVC source material
to monitor the

of certain

elements

or

Results
Microstructure
The surface
of the uncoated
polyvinyl
chloride
(PVC) tubing is smooth (Figure
lalb).
By comparison,
the surface
of the uncoated radiopaque
PVC tubing is rough (Figure
2).
The hydrogel
coating
that results
from the
dip processing
is also smooth.
Only minor surface blemishes
are seen on such surfaces.
Typically
the hydrogel-antibiotic
mixture is
built
up as a result
of several
consecutive
coatings,
and as a result
the hydrogel
surfaces
on the radiopaque
PVC tubing appear smooth.
The exposure
to the elution
solution
for the
nine day test periods
does not appear to alter
the surface
appearance
(Figure 3).
Since the
elution
solution
was Ringer's,
a number of small
sodium chloride
crystals
are seen on the hydrogel surface
after
a test.
Ring device joints
should be monitored
to avoid forming rough portions of a ring such as that seen in Figure 4.
Also, attempts
to smooth dip coated surfaces
with a brush before the coating
hardens can
result
in forming a variety
of surface
grooves.
Although such surface
features
are
small,
and probably
would cause no major
problems in using a ring with such features
as an insert
in the eye of a cow, such
handling
is unnecessary,
and should be
avoided.
Microchemistry
The use of energy dispersive
X-ray
analysis
shows the presence
of a chemical
difference
between the two types of PVC
tubing.
An analysis
performed on a gold
coated segment of plain PVC tubing shows the
presence
of the gold (300 angstrom coating
thickness)
and the chlorine
of the underlying
PVC tubing
(Figure
5).
By comparison,
in
addition
to these peaks,
the presence
of
iodine is seen in the radiopaque
PVC tubing
(Figure
6).
Also note that the hydrogel
coating
completely
covers these surfaces
to
a thickness
of approximately
0.025cm (dry
state;
spectrum
shown in Figure 7).
These
chemical
elements,
as well as other components such as plasticizers,
which are in the
medical grade PVC tubings,
are not expected
to
cause eye irritation
during the typical
insertion
periods
of several
days (based on
observations
reported
in the literature
by
Hughes and Pugh).
Release Rates
Within the first
8 h of contact
with the
elution
solution,
the maximum release
rate is
seen (Figure
8a-8c).
For typical
ring
devices,
such as those listed
in Table 1,
(hydrogel
coated radiopaque
PVC for these
cases)
the maximum rate is of the order of
several
hundred micrograms per hour.
After the
release
rate peak is reached,
the release
rate
falls
off rapidly.
During the first
three days
of a release
experiment,
the release
rate of
antibiotic
is above 50 micrograms
per hour.
At
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Figure la.
Plain
dip coating).

PVC tubing

surface

and J. P. Ryoc

(before

Figure 3. Hydrogel surface
coating
on radiopaque PVC tubing after
9-day in vitro
antibiotic
release
test.
Arrow indicaee"s sodium
chloride
residue
from the Ringer's
solution.
Note that the hydrogel
surface
is smooth and
similar
to that for a sample prior to a drug
release
test
(i.e.,
similar
smoothness and
no salt crystals).

Figure lb.
PVC sample

Higher magnification
of Figure la.

view of plain

0020

-

5KU

X40 100~m WD25

Figure 4.
lncomplete
seal
hydrogel
coated radiopaque

of a PVC ring
tubing.

nine days, the release
rate is
least
3 micrograms per hour.

seen

joint;

to be at

Conclusion
The physical
and chemical characteristics
of the ring device appear to be satisfactory
for use as an ocular
insert
for cattle.
The
in vitro
tests
were performed on rings of
sizes of interest
for use as ocular inserts
for cattle
(results
were reported
above for a
typical
diameter
and circumference
that might
be needed; for best retention,
Hughes and
Pugh (1975) recommend that such devices meet

Figure 2.
Radiopaque PVC tubing surface
(before
dip coating).
Compare with Figure lb, and note
that the surface
of this type of PVC tubing is
relatively
rough (extrusion
marks).
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the following
criterion:
rings
should
have a
circumference
smaller
than that
of the conjunctiva!
sac,
but larger
than that
of the
globe of the eye).
The hydrogel
coating
appears
to release
a sufficient
amount of
antibiotic
to remain
above the minimal
inhibitory
concentration
necessary
to
suppress
bacterial
growth.
It is anticipated
that
the inserts
would be effective
for therapeutic
administration
of the
antibiotic
throughout
a 5 to 7 day period
at a
rate
at least
of the order
of a few micrograms
per hour.
For the tearing
rate
ranges
reported
for cattle,
the ocular
insert
prototype has potential
application
in treating
pinkeye
in cattle.
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Table

1.

Release

Device
Number

Rate

Characteristics

for LO Millimeter

Diameter

Ring Devices

Release Rate
After 6
Days
(µg/hr)

Release Rate
Maximum
Achieved During
First
Two Days
(µg/hr)

061
062
063
064
065

P. Ryoo

682
626
632
925
629

3
3
4
3
6

to
to
to
to
to

(50 mg loading).
Total
Total

Total
Release
Rate
(µg)

22
8
12
7

16363
16978
18273
18181
15851

13

Released
Loading
(%)

32.2
35.4
34.6
36.8
28.7
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Figure 8.
Curves of the release
rate of the
antibiotic
(µg/hr)
versus
time (hr) and of the
total
amount of antibiotic
released
(mg) as a
function
of time (hr) obtained
from hydrogel
coated PVC rings
(50 mg antibiotic
loading;
40 mm diameter).
(a) Ring device 061, (b) ring
device 062, and (c) ring device 063.
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Cristopher
D. Batich and Moshe Yalon:
After
testing
release
rates,
had the hydrogel
been
damaged?
Mechanical
properties
of hydrogels
are very poor and one would expect significant
abrasion
in vivo.
Authors:
No--:---i>lease refer
to Figure 3 in the
paper for an in vitro
example, and to Figure 9
(below) for a-;:;:--invivo example.
Preliminary
in
vivo experiments
are being conducted
in
collaboration
with Dr. R. Rosenbusch (Veterinary
Medical Research Institute,
Iowa State
University).
Problems of insertion
and retention of rings have been identified,
and
associated
studies
are in progress.

Cristopher
D. Batich and Moshe Yalon:
Has any
monomer or oligomer extraction
been studied
for
potential
toxic effects
on the eye?
Authors:
We have not done such studies.
Alan H. Brightman:
Was there another
copolymer precipitated
and studied?
Authors:
A relatively
hydrophilic
formulation
of 75 mole percent
hydroxyethyl
methacrylate
25 mole percent
methyl methacrylate
(25 MMA:
75 HEMA) was also studied.
The release
rate
profiles
for ring devices
utilizing
a coating
of this formulation
were similar
to that of
the 90:10 copolymer coatings
reported
above.
The 25 MMA:75 HEMAformulation
was studied
as
a type of matrix for the antibiotic
that
would be expected
to exhibit
minimal eye
irritation.
No overt inflammation
was
observed in limited
preliminary
in vivo
testing
of the 90:10 copolymer coating
on a
ring device (1 week).
No in vivo tests
have
been done using the 25 MMA~S HEMAformulation.
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Cristopher
D. Batich and Moshe Yalon:
Why are
different
release
rates
seen for the three
samples?
Are the same thickness
coatings
used?
Authors:
The PVC tubing shrinks
(shortens)
in
response
to the solvent
of the dipping treatment.
The coating
thicknesses
are about the
same in each case; however, the tube lengths
vary.
The longer a tube, the more surface
area, and the greater
the amount of drug
release
during the sampling periods.
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Figure 9.
Surface of an ocular
insect
after
a
7-day in vivo antibiotic
release
experiment
in
th1e eye ofa
healthy
cow. Notice that the
hY'drogel surface
is intact.
(Sample was fixed
in a 3% glutaraldehyde
solution,
critical
paint
dried using co2 , and gold coated prior to
SEM examination).

Alan H. Brightman:
Do the authors
feel that
other antibiotics
could be incorporated
into
this coating?
Authors:
Yes.
Other antibiotics
such as
lincomycin
are of interest.
However, you need
a sensitive
method to quantify
the release
of
particular
antibiotics
for the time period of
interest.

R. Holm: In figure
7, why is iodine detected
while chlorine
is not?
Did iodine migrate into
the hydrogel?
Authors:
Chlorine
X-rays are absorbed by the
thickness
of the hydrogel
coating,
whereas
those from iodine are less affected
and can be
detected
by energy dispersive
X-ray analysis
in
this
case.

Cristopher
D. Batich and Moshe Yalon:
What is
the source of the PVC tubing?
Many varieties
are commercially
available.
Authors:
The source of the PVC for the
experiments
reported
above is Becton,
Dickinson
and Co., Rutherford,
NJ. The PVC
material
with iodine is the transparent/
radiopaque
type (Clearex
#15654 and #15652,
sizes 0.086cm i.d. x 0.117cm o.d. and 0.051cm
i.d. x 0.091cm o.d.,
respectively).
The other
variety
is plain medical grade vinyl tubing
(B-D #6179; 0.112cm i.d.
x 0.165 cm o.d.;
discontinued).

R. Holm: Does the tylosin
tartrate
exhibit
cathodoluminescence?
Authors:
We do not have cathodoluminescence
information.
However, optical
fluorescence
of
the powder is excited
by short wavelength
(254 nm) ultraviolet
light
(brown fluorescence
emission),
by long wavelength
(365 nm) ultrav~olet
light
(bright
yellow fluorescence
emission),
or by both short and long wavelength
ulitraviolet
light
(dark brown fluorescence
emission).
This is of interest
in a general
way in the TLC method.
In spotting
the antib~otic
on the TLC plates,
ultraviolet
light
can
be used to excite
a green luminescence
for the
pliate,
whereas the antibiotic
spots appear
bliack (for both long and short wavelength
ulitraviolet
and combined ultraviolet).

Alan H. Brightman:
If the devices are used as
intended,
does the coating
withstand
physical
handling
necessary
to insert
a ring into a
cow's eye?
Authors:
Yes.
A ring is placed in physiological saline
for 8-12 h prior to insertion.
This
is a preconditioning
step to soften
the
hydrogel
coating.
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